Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

International Flavors & Fragrances Inc Stock Research

IFF

65.97USD-2.20(-3.23%)Market Closed
Watchlist

Market Summary

USD65.97-2.20
Market Closed
-3.23%

IFF Alerts

IFF Stock Price

IFF RSI Chart

IFF Valuation

Market Cap

17.4B

Price/Earnings (Trailing)

-7.92

Price/Sales (Trailing)

1.47

EV/EBITDA

-39.53

Price/Free Cashflow

65.65

IFF Price/Sales (Trailing)

IFF Profitability

EBT Margin

-15.49%

Return on Equity

-11.92%

Return on Assets

-5.97%

Free Cashflow Yield

1.52%

IFF Fundamentals

IFF Revenue

Revenue (TTM)

11.9B

Revenue Y/Y

-11.43%

Revenue Q/Q

-3.24%

IFF Earnings

Earnings (TTM)

-2.2B

Earnings Y/Y

-74.77%

Earnings Q/Q

400%

Price Action

52 Week Range

62.11118.34
(Low)(High)

Last 7 days

0.5%

Last 30 days

-2.3%

Last 90 days

-14.3%

Trailing 12 Months

-25.6%

IFF Financial Health

Current Ratio

1.53

IFF Investor Care

Dividend Yield

4.75%

Dividend/Share (TTM)

3.24

Shares Dilution (1Y)

0.09%

Diluted EPS (TTM)

-8.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for IFF

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-01
Borg Deborah
sold (taxes)
-856,628
70.25
-12,194
evp, chief hr and d&i officer
2023-09-01
Borg Deborah
acquired
-
-
27,614
evp, chief hr and d&i officer
2023-05-11
Fauchon de Villeplee Christophe
sold
-170,282
86.35
-1,972
president, scent
2023-05-04
O'Byrne Kevin
acquired
-
-
262
-
2023-05-04
Bruno Barry A.
acquired
-
-
1,245
-
2023-05-04
Hu Gaoxiang
acquired
-
-
434
-
2023-05-04
Costa Mark J
acquired
-
-
468
-
2023-05-04
Gold Christina A
acquired
-
-
1,245
-
2023-05-04
Willoughby Dawn C
acquired
-
-
434
-
2023-04-06
Yep Gregory L
sold (taxes)
-67,032
91.45
-733
evp, chief scientific officer

1–10 of 50

Which funds bought or sold IFF recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
186
44,716,000
74,865,000
0.05%
2023-09-14
IMS Capital Management
sold off
-100
-248,292
-
-%
2023-09-12
Farther Finance Advisors, LLC
reduced
-41.2
-9,755
10,108
-%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
unchanged
-
-1,336
8,596
-%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
-49.00
319
-%
2023-09-01
Portside Wealth Group, LLC
new
-
736,211
736,211
0.14%
2023-08-28
BASSETT HARGROVE INVESTMENT COUNSEL, LLC
added
0.15
90,000
708,000
1.33%
2023-08-24
Alberta Investment Management Corp
unchanged
-
-660,558
4,250,110
0.04%
2023-08-23
HEADINVEST, LLC
sold off
-100
-361,403
-
-%
2023-08-23
Stonebridge Capital Advisors LLC
unchanged
-
-631
4,059
-%

1–10 of 48

Latest Funds Activity

Are funds buying IFF calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own IFF
No. of Funds

Schedule 13G FIlings of International Flavors & Fragrances

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 05, 2023
winder investment pte ltd
0%
0
SC 13G/A
Feb 09, 2023
vanguard group inc
12.52%
31,920,258
SC 13G/A
Feb 03, 2023
blackrock inc.
8.6%
21,920,824
SC 13G/A
Feb 14, 2022
alliancebernstein l.p.
1.5%
3,768,731
SC 13G/A
Feb 10, 2022
vanguard group inc
11.89%
30,267,303
SC 13G/A
Feb 10, 2022
winder investment pte ltd
9.9%
25,109,000
SC 13G/A
Feb 04, 2022
winder investment pte ltd
9.9%
25,109,000
SC 13D/A
Feb 01, 2022
blackrock inc.
7.5%
19,198,319
SC 13G/A
Feb 10, 2021
vanguard group inc
10.03%
10,730,935
SC 13G/A
Feb 08, 2021
alliancebernstein l.p.
7.2%
7,654,749
SC 13G/A

Recent SEC filings of International Flavors & Fragrances

View All Filings
Date Filed Form Type Document
Sep 19, 2023
8-K
Current Report
Sep 06, 2023
4
Insider Trading
Aug 09, 2023
10-Q
Quarterly Report
Aug 07, 2023
8-K
Current Report
Jul 05, 2023
SC 13G/A
Major Ownership Report
Jul 05, 2023
4
Insider Trading
Jul 05, 2023
4
Insider Trading
Jun 28, 2023
11-K
Employee Benefit Details

IFF Fair Value

Loading...

Peers (Alternatives to International Flavors & Fragrances)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
30.7B
43.0B
-4.27% 28.32%
14.54
0.71
-19.65% -61.23%
17.4B
11.9B
-2.34% -25.56%
-7.92
1.47
-6.11% -441.15%
15.9B
13.9B
-6.40% 46.70%
11.9
1.15
-8.20% -53.46%
12.2B
7.3B
-5.00% 13.36%
25.5
1.68
8.18% -2.60%
-
17.9B
-8.62% 16.92%
-
-
1.96% 21.57%
MID-CAP
-
5.1B
-5.48% 26.23%
-
-
9.03% 9.70%
6.3B
7.8B
-15.12% 18.82%
7.76
0.8
-20.33% -46.41%
4.4B
2.8B
-3.00% 53.10%
12.43
1.58
7.02% 79.95%
2.5B
1.5B
-5.17% -16.29%
18.51
1.69
2.92% -2.93%
SMALL-CAP
313.8M
395.4M
-0.55% 22.01%
7.48
0.79
6.42% 107.62%
-
1.4B
-5.43% -0.74%
-
-
-5.70% -3.36%
29.3M
268.2M
-95.00% -98.59%
-0.05
0.11
20.46% -592.58%

International Flavors & Fragrances News

InvestorsObserver
Should You Hold International Flavors & Fragrances Inc (IFF) Stock Monday?.
InvestorsObserver,
4 hours ago

Returns for IFF

Cumulative Returns on IFF

-0.1%


10-Year Cumulative Returns

-8.3%


7-Year Cumulative Returns

-11.7%


5-Year Cumulative Returns

-16.3%


3-Year Cumulative Returns

Risks for IFF

What is the probability of a big loss on IFF?

74.6%


Probability that International Flavors & Fragrances stock will be more than 20% underwater in next one year

27.7%


Probability that International Flavors & Fragrances stock will be more than 30% underwater in next one year.

10.4%


Probability that International Flavors & Fragrances stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IFF drawdown profile look like?

Y-axis is the maximum loss one would have experienced if International Flavors & Fragrances was unfortunately bought at previous high price.

Drawdowns

Financials for International Flavors & Fragrances

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue-3.1%11,86312,24112,44012,62712,63512,41711,6569,8958,0926,2025,0845,0985,0975,1905,1405,0754,7164,3443,9783,6133,579
Gross Profit-5.1%3,7673,9704,1514,2634,3524,1263,7353,2682,7022,2742,0862,0742,0842,1482,1132,0881,9561,8081,6831,5611,541
  S&GA Expenses-0.6%1,7521,7631,7681,7781,8011,7571,7491,5531,3521,170949937913893876884831778707599587
  R&D Expenses0.5%610607603626637643629564497414357342338341346344334324312305304
EBITDA100.0%--369-110-9.002,2712,2061,7991,5101,1128848989249711,0321,019------
EBITDA Margin100.0%--0.03*-0.01*0.00*0.54*0.18*0.15*0.15*0.14*0.14*0.18*0.18*0.19*0.20*0.20*------
Interest Expenses10.4%414375336305296296289249210165132134133133138141132153133110105
Earnings Before Taxes-4.2%-1,976-1,896-1,625-1,506779693354319174234441458510575557527471423448497537
EBT Margin100.0%--0.15*-0.13*-0.12*0.19*0.06*0.03*0.03*0.02*0.04*0.09*0.09*0.10*0.11*0.11*------
Net Income-3.8%-2,197-2,117-1,864-1,747644565279251142201367384426475460388356319340284299
Net Income Margin100.0%--0.17*-0.15*-0.14*0.15*0.05*0.02*0.03*0.02*0.03*0.07*0.08*0.08*0.09*0.09*------
Free Cashflow100.0%--19.00-1075.001756431,0441,115927819522531525441463------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-1.4%34,45934,96535,47035,50434,53739,30439,74739,65840,25240,86440,81713,55513,08512,98912,68913,28712,98513,34813,21112,8899,616
  Current Assets-6,436-7,4427,4326,4947,7307,5076,9877,1326,2976,1743,0602,9463,0132,8182,9432,8992,9902,9262,9426,947
    Cash Equivalents4153.3%63815.005904835385696577116729358726504704984336244954274846495,274
  Inventory2305.2%2,7901162,9463,1513,1222,9932,7952,5162,4012,4642,5891,1321,1511,1661,0761,1231,1261,1641,1141,079720
  Net PPE5377.9%4,21877.004,2244,2034,0554,1774,2954,3684,2954,5664,5871,4581,3801,3561,3391,3871,3141,3161,2941,241875
  Goodwill4158.0%13,49831713,45813,35513,30516,07145.0016,41416,59017,25011,7625,5935,4275,34915.005,4974,2745,5065,4345,3784,243
  Current Liabilities-3,932-4,8743,7283,6264,7204,0323,6333,5793,2273,2611,9041,6161,3441,4271,5521,4121,1501,1441,128758
    LT Debt, Non Current-9,208-9,22010,37310,26010,36310,73810,76810,81811,35411,3303,7793,8914,1823,9473,9974,0084,4294,4214,5044,331
Shareholder's Equity42882.9%17,62341.0017,76117,65516,88720,29320,96521,11721,47321,80021,6816,3226,0906,0015,8416,2296,0676,2106,1546,0434,038
  Retained Earnings-560-7399551,1863,5893,6833,6413,7523,7593,9224,1564,1714,1684,1624,1184,1144,0694,0113,9564,021
  Additional Paid-In Capital-19,851-19,84419,84119,83219,82619,82319,82619,81719,80019,7963,8533,8483,8383,8353,8233,8163,8063,8033,7942,442
Accumulated Depreciation-2,186-2,0851,9771,9781,9611,8891,7931,6081,5821,5011,4701,4091,3421,2931,3041,3031,3151,2871,2521,250
Shares Outstanding-255-25525525525525525525425420610711211211210711211211210781.00
Minority Interest-32.00-32.0030.0034.0033.0032.0035.0047.0039.0039.0012.0012.0013.0013.0012.0011.0011.0011.0010.006.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations55.9%8235283975006881,0751,4371,4251,2041,055714731722669699619567496438393388
  Share Based Compensation7.7%56.0052.0049.0047.0052.0052.0054.0053.0044.0038.0036.0035.0035.0035.0034.0034.0033.0029.0029.0028.0029.00
Cashflow From Investing135.1%1,643699745794-394-254-18.007.00-80.00-29.00-187-187-156-178-226-5,068-5,090-5,068-5,013-139-137
Cashflow From Financing-98.4%-2,472-1,246-1,229-1,369-500-994-1,304-1,116-724-620-512-557-485-499-505-3164,6614,7734,8714,721-410
  Dividend Payments0.7%821815810805795786667549437325323321318316314300277254230218214
  Buy Backs------------------4.0015.0020.0020.00

IFF Income Statement

2023-06-30
CONSOLIDATED STATEMENT OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Millions, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales$ 2,929$ 3,307$ 5,956$ 6,533
Cost of goods sold1,9962,1714,0594,252
Gross profit9331,1361,8972,281
Research and development expenses161158322315
Selling and administrative expenses445456899915
Amortization of acquisition-related intangibles172184343370
Impairment of long-lived assets01200120
Restructuring and other charges77599
Gain (Loss) on Disposition of Assets(3)222
Operating profit145213276554
Interest expense11677227149
Other (income) expense, net(21)6(15)(10)
Income before taxes5013064415
Provision for income taxes23214560
Net income2710919355
Net income attributable to non-controlling interests0214
Net income attributable to IFF shareholders$ 27$ 107$ 18$ 351
Net income per share - basic (in dollars per share)$ 0.11$ 0.43$ 0.07$ 1.38
Net income per share - diluted (in dollars per share)$ 0.11$ 0.43$ 0.07$ 1.38
Average number of shares outstanding - basic (in shares)255255255255
Average number of shares outstanding - diluted (in shares)255255255255
Dividends declared per share, in dollars per share$ 0.81$ 0.79$ 1.62$ 1.58
Other comprehensive income (loss), after tax:    
Foreign currency translation adjustments$ 60$ (589)$ 344$ (788)
Pension and postretirement liability adjustment(1)1(3)1
Net current period other comprehensive income (loss)59(588)341(787)
Comprehensive income (loss)86(479)360(432)
Comprehensive income (loss) attributable to IFF shareholders$ 86$ (481)$ 359$ (436)

IFF Balance Sheet

2023-06-30
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 638$ 483
Restricted cash1110
Trade receivables1,8871,818
Inventories:  
Raw materials9191,073
Work in process474442
Finished goods1,3971,636
Total Inventories2,7903,151
Assets held for sale2121,200
Prepaid expenses and other current assets898770
Total Current Assets6,4367,432
Property, plant and equipment, at cost6,4046,180
Accumulated depreciation(2,186)(1,977)
Total Property Plant and Equipment4,2184,203
Goodwill13,49813,355
Other intangible assets, net8,8139,082
Operating lease right-of-use assets740743
Other assets754689
Total Assets34,45935,504
Current Liabilities:  
Bank borrowings, overdrafts, and current portion of long-term debt1,203410
Commercial paper159187
Accounts payable1,2271,418
Accrued payroll and bonus205267
Dividends payable206206
Liabilities held for sale13212
Other current liabilities9191,028
Total Current Liabilities3,9323,728
Long-term debt9,20810,373
Retirement liabilities233231
Deferred income taxes2,1832,265
Operating lease liability683672
Other liabilities504491
Total Other Liabilities12,81114,032
Commitments and Contingencies
Redeemable non-controlling interests6159
Shareholders' Equity:  
Common Stock, Value, Issued3535
Capital in excess of par value19,85119,841
Retained earnings560955
Accumulated other comprehensive loss(1,857)(2,198)
Treasury Stock, Value(966)(978)
Total Shareholders’ Equity17,62317,655
Non-controlling interest3230
Total Shareholders’ Equity including Non-controlling interest17,65517,685
Total Liabilities and Shareholders’ Equity$ 34,459$ 35,504
Franklin K. Clyburn
24000
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.